Benefit-Risk Assessment of the Levonorgestrel Intrauterine System in Contraception

被引：0
作者：
Tiina Backman
机构：
[1] Turku University Hospital,Department of Obstetrics and Gynecology
来源：
Drug Safety | 2004年 / 27卷
关键词：
Ectopic Pregnancy; Contraceptive Method; Pelvic Inflammatory Disease; Levonorgestrel; Menstrual Bleeding;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The levonorgestrel-releasing intrauterine system (IUS) is a long-acting, fully reversible method of contraception. It is one of the most effective forms of contraception available, and combines the advantages of both hormonal and intrauterine contraception. The levonorgestrel-releasing IUS also gives the users many non-contraceptive benefits: the amount of menstrual bleeding and the number of days of menstrual bleeding are reduced, which makes it suitable for the treatment of menorrhagia (heavy menstrual blood loss). Dysmenorrhoea (painful menstruation) and premenstrual symptoms are also relieved. In addition, the levonorgestrel-releasing IUS provides protection for the endometrium during hormone replacement therapy.
引用
收藏
页码：1185 / 1204
页数：19
相关论文
共 426 条
[1]  
Sivin I(1991)Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20μg/day (LNg 20) and the Copper T 380Ag IUDs Contraception 44 473-80
[2]  
Mahgoub SE(1989)Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device Contraception 39 195-204
[3]  
Coutinho E(1986)Five years’ experience with levonorgestrel-releasing IUDs Contraception 33 139-48
[4]  
Ratsula K(1983)Two years experience with two levonorgestrel-releasing and one copper-releasing intrauterine device: a randomised comparative study Fertil Steril 39 187-92
[5]  
Toivonen J(1994)Health during prolonged use of levonorgestrel 20μg/d and the copper Tcu 380Ag intrauterine contraceptive devices: a multicenter study: International Committee for Contraception Research (ICCR) Fertil Steril 61 70-7
[6]  
Lähteenmäki P(1993)Clinical experience with a levonorgestrel releasing intrauterine contraceptive device (LNG IUD) as a contraceptive and in the treatment of menorrhagia Br J Fam Plann 19 193-4
[7]  
Luukkainen T(1995)Transdermal estradiol with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses Am J Obstet Gynecol 172 114-9
[8]  
Allonen H(1992)Intrauterine release of levonorgestrel: a new way of adding progestogen in hormone replacement therapy Obstet Gynecol 97 963-7
[9]  
Haukkamaa M(1995)Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy Fertil Steril 63 336-42
[10]  
Nilsson CG(1991)Levonorgestrel-releasing intrauterine device Ann N Y Acad Sci 626 43-9
12345678910